Oncologists demand more education on the use of biosimilars. ESMO takes action
byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ
Updated on: December 18,2023
16
Oncologists demand more education on the use of biosimilars. ESMO takes action
byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ
Updated on:December 18,2023
16
